Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2011(14): 2215-2222
DOI: 10.1055/s-0030-1260069
DOI: 10.1055/s-0030-1260069
SPECIALTOPIC
© Georg Thieme Verlag
Stuttgart ˙ New York
Diversity-Oriented Synthesis of Functionalized Polyheterocycles from Garner Aldehyde
Further Information
Received
9 April 2011
Publication Date:
15 June 2011 (online)
Publication History
Publication Date:
15 June 2011 (online)
Abstract
We report a diversity-oriented synthesis of diverse drug-like polyheterocycles from Garner aldehyde derived 1-hydroxy-1,3-dihydroisobenzofuran 20 as a key intermediate. The oxonium-mediated nucleophilic addition of 20 in the presence of boron trifluoride-diethyl ether complex provided enantiopure 1,3-disubstituted 1,3-dihydroisobenzofurans through 1,3-asymmetric induction. Further diversification of 20 allowed the diastereoselective syntheses of drug-like polyheterocycles including the 3-substituted isobenzofuran-1(3H)-one, 2,3-dihydro-1H-isoindol-1-one, and 3,4-disubstituted dihydroisoquinolinone ring systems.
Key words
diversity-oriented synthesis - Garner aldehyde - isobenzofuran - isoindole - isoquinoline
- Supporting Information for this article is available online:
- Supporting Information
-
1a
Drews J. Nat. Biotechnol. 1996, 14: 1516 -
1b
Reiss T. Trends Biotechnol. 2001, 19: 496 - 2
Schreiber SL. Science 2000, 287: 1964 - 3
Bruke MD.Schreiber SL. Angew. Chem. Int. Ed. 2004, 43: 46 - 4
Tan DS. Nat. Chem. Biol. 2005, 1: 74 - 5
Lipkus AH.Yuan Q.Lucas KA.Funk SA.Bartelt WF.Schenck RJ.Trippe AJ. J. Org. Chem. 2008, 73: 4443 - 6
Painter TO.Wang L.Majumder S.Xie X.-Q.Brummond KM. ACS Comb. Sci. 2011, 13: 166 -
7a
Oh S.Jang HJ.Ko SK.Ko Y.Park SB. J. Comb. Chem. 2010, 12: 548 -
7b
Kim Y.Kim J.Park SB. Org. Lett. 2009, 11: 17 -
7c
Sagar R.Park SB. J. Org. Chem. 2008, 73: 3270 -
7d
Sagar R.Park J.Koh M.Park SB. J. Org. Chem. 2009, 74: 2171 -
7e
Lee S.-C.Park SB. J. Comb. Chem. 2006, 8: 50 -
7f
Lee S.-C.Choi SY.Chung YK.Park SB. Tetrahedron Lett. 2006, 47: 6843 -
7g
Lee S.-C.Park SB. J. Comb. Chem. 2007, 9: 828 -
7h
Lee S.-C.Park SB. Chem. Commun. 2007, 3714 -
8a
Oh S.Cho SW.Yang JY.Sun HJ.Chung YS.Shin CS.Park SB. Med. Chem. Commun. 2011, 2: 76 -
8b
Oh S.Nam HJ.Park J.Beak SH.Park B. ChemMedChem 2010, 5: 529 -
8c
Oh S.Kim SJ.Hwang JH.Lee HY.Ryu MJ.Park J.Kim SJ.Jo YS.Kim YK.Lee CH.Kweon KR.Shong M.Park SB. J. Med. Chem. 2010, 53: 7405 -
8d
Zhu M.Kim MH.Lee S.Kim SH.Park SB. J. Med. Chem. 2010, 53: 8760 - 9
Srivastava AK.Koh M.Park SB. Chem. Eur. J. 2011, 17: 4905 - 10
Katagiri K.Tori K.Kimura Y.Yoshida T.Nagasaki T.Minato H. J. Med. Chem. 1967, 10: 1149 - 11
Donati C.Prager RH.Weber B. Aust. J. Chem. 1989, 42: 787 - 12
Hardcastle IR.Liu J.Valeur E.Watson A.Ahmed SU.Blackburn TJ.Bennaceur K.Clegg W.Drummond C.Endicott JA.Golding BT.Griffin RJ.Gruber J.Haggerty K.Harrington RW.Hutton C.Kemp S.Lu X.McDonnell JM.Newell DR.Noble MEM.Payne SL.Revill CH.Riedinger C.Xu Q.Lunec J. J. Med. Chem. 2011, 54: 1233 - 13
Lopes ECS.Coelho F. J. Braz. Chem. Soc. 2007, 18: 1415 - 14
Coote SJ.Davies SG. J. Organomet. Chem. 1989, 379: 81 - 15
Fort Y.Gros P.Rodriguez AL. Tetrahedron Lett. 2002, 43: 4045 - 16
Chai Z.Xie Z.-F.Liu X.-Y.Zhao G.Wang J.-D. J. Org. Chem. 2008, 73: 2947 - 17
Capriati V.Florio S.Luisi R.Perna FM.Salomone A. J. Org. Chem. 2006, 71: 3984 -
18a
Mikami K.Ohmura H. Org. Lett. 2002, 4: 3355 -
18b
Hobson SJ.Parkin A.Marquez R. Org. Lett. 2008, 10: 2813 -
18c
Tobia D.Rickborn B. J. Org. Chem. 1986, 51: 3849 -
18d
Ohmura H.Smyth GD.Mikami K. J. Org. Chem. 1999, 64: 6056 -
18e
Selouane A.Vaccher C.Villa P.Postela D.Len C. Tetrahedron: Asymmetry 2002, 13: 407 - 19
Himo F.Lovell T.Hilgraf R.Rostovtsev VV.Noodleman L.Sharpless KB.Fokin VV. J. Am. Chem. Soc. 2005, 127: 210